Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2002
05/10/2002WO2002036589A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
05/10/2002WO2002036576A1 Phthalazinone derivatives
05/10/2002WO2002036570A1 4-substituted quinolines as antitumor agents
05/10/2002WO2002036564A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors
05/10/2002WO2002036562A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
05/10/2002WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
05/10/2002WO2002036555A1 Sulfamides as gamma-secretase inhibitors
05/10/2002WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/10/2002WO2002036553A2 Substituted alkanoic acids
05/10/2002WO2002036116A2 Tripeptidyl peptidase inhibitors
05/10/2002WO2002022600A3 Chemokine receptor binding heterocyclic compounds
05/10/2002WO2002020437A3 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them
05/10/2002WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/10/2002WO2001081342A3 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
05/10/2002WO2001070706A3 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
05/10/2002WO2001040236A3 Phosphorylation of terminal primary alcohol groups
05/10/2002WO2001038324A3 Imidazole derivatives and their use as raf kinase inhibitors
05/10/2002WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
05/10/2002CA2427589A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
05/10/2002CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
05/10/2002CA2427394A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
05/10/2002CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/09/2002US20020055641 Synthesis of 1,3,5-trisubstituted pyrazoles
05/09/2002US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
05/09/2002US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/09/2002US20020055508 Benzofurazan compounds which enhance AMPA receptor activity
05/09/2002US20020055507 Ureas and thioureas inhibit production of cytokines
05/09/2002US20020055505 Sultam and sultone derived oxazolidinones
05/09/2002US20020055498 Benzofurazan compounds for enhancing glutamatergic synaptic responses
05/09/2002US20020055483 Treating hepatitus B, C and D; AIDS; antiproliferative agents
05/08/2002EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases
05/08/2002EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
05/08/2002EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them
05/08/2002EP1202985A2 Chemokine receptor antagonists
05/08/2002EP1202984A1 Novel diphenyl-piperidine derivate
05/08/2002EP1202978A1 Isoxazolyl- and isoxazolinyl-substituted benzoylcyclohexanediones, production method and use thereof as herbicides and plant growth regulators
05/08/2002EP1202976A1 Pyrazinones, compositions containing such compounds
05/08/2002EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
05/08/2002EP1202966A1 Piperidine alcohols
05/08/2002EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof
05/08/2002EP1087966B1 Chemical synthesis of morpholine derivatives
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/08/2002CN1347878A Halogenated pyrimidines and its application as a method for reducing parasite
05/07/2002US6384070 Restenosis, kidney diseases, lung diseases
05/07/2002US6384066 Sulphonyltriazol derivatives and their use for combating micro-organisms
05/07/2002US6384052 Anticoccidial compounds
05/07/2002US6384035 Heterocycles useful in the treatment of benign prostatic hyperplasia
05/07/2002US6384030 Water soluble azoles as broad-spectrum antifungals
05/07/2002US6384029 Optically active pyridyl-4h-1,2,4-oxdadiazine derivative and its use in the treatment of vascular diseases
05/07/2002US6384028 Treatment of cardiovascular disorders, anticoagulants and valve replacement
05/07/2002US6383988 Thienysulfonylamino (thio) carbonyl compounds
05/07/2002US6383986 Use as herbicides, desiccants or defoliants and plant safening agents
05/07/2002US6383666 Organometallic complex and organic electroluminescent device using the same
05/07/2002CA2098612C Arthropodicidal carboxanilides
05/02/2002WO2002034760A2 Compounds and methods
05/02/2002WO2002034754A2 Benzoxazinone derivatives, their preparation and use
05/02/2002WO2002034745A1 Chemokine receptor binding heterocyclic compounds
05/02/2002WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002WO2002034725A1 Substituted phenyluracils
05/02/2002WO2002034699A2 Mammalian metabolites of a tachykinin receptor antagonist
05/02/2002WO2001070733A3 Di-substituted iminoheterocyclic compounds
05/02/2002WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
05/02/2002WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors
05/02/2002US20020052693 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists
05/02/2002US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
05/02/2002US20020052513 Oxamide IMPDH inhibitors
05/02/2002US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
05/02/2002US20020052503 Substituted benzolactam compounds as substance p antagonists
05/02/2002US20020052393 Benzanilides as potassium channel openers
05/02/2002US20020052392 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/02/2002US20020052386 Pyrimidine derivatives
05/02/2002US20020052375 3-(Heteroaryal) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
05/02/2002US20020052357 Cyclic oxyguanidine pyrazinones as protease inhibitors
05/02/2002US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides
05/02/2002EP1201661A1 Heteroaromatic ring compounds
05/02/2002EP1201660A1 Glucocorticoid receptor modulators
05/02/2002EP1200429A1 1-cycloalkylpyrazoyl-benzoyl derivatives
05/02/2002EP1200428A1 Substituted benzoxazoles
05/02/2002EP1200427A2 Small molecule modulators of g protein-coupled receptor six (gpr6)
05/02/2002EP1200416A1 Oxazolidinones and their use as antiinfectives
05/02/2002EP0615448B1 Sex steroid activity inhibitors
05/02/2002DE10051981A1 Substituierte Phenyluracile Substituted Phenyluracils
05/02/2002CA2426706A1 Benzoxazinone derivatives, their preparation and use
05/02/2002CA2425908A1 Mammalian metabolites of a tachykinin receptor antagonist
05/02/2002CA2425884A1 Substituted phenyluracils
05/02/2002CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002CA2421796A1 Chemokine receptor binding heterocyclic compounds
05/01/2002CN1347414A Triazole compounds with dopamine-D3-receptor affinity
05/01/2002CN1347411A Sulfonamide derivs. having oxadiazole rings
05/01/2002CN1347406A Carbamic acid derivs. and their use as metabotropic glutamate receptor ligands
05/01/2002CN1347318A Inhibitors of IMPDH enzyme
05/01/2002CN1346826A Microbicidal halobenzoimidazole, composition and process for preparing same
05/01/2002CN1083839C Novel compound and use thereof
04/2002
04/30/2002US6380394 Anticancer agents
04/30/2002US6380386 Insecticides, bactericides
04/30/2002US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
04/30/2002US6380241 For therapy of coronary angina, cerebral vasospasm, acute and chronic renal failure, gastric ulceration, cyclosporin-induced nephrotoxicity, endotoxin-induced toxicity, asthma, lpl-related lipoprotein disorders, proliferative diseases
04/30/2002US6380233 Indole derivatives as 5-HT1 agonists
04/30/2002US6380225 Microbicidal benzotriazoles
04/30/2002US6380223 For therapy of diseases, such as obesity, diabetes, inflammation